PA
HP icon

PharVision Advisers’s Helmerich & Payne HP Stock Holding History

PharVision Advisers’s Portfolio HP Stock Details HP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,886
Closed -$284K – 349
2025
Q4 		$284K Buy
+9,886
New +$263K 0.14% 306
2025
Q2 		– Sell
-9,473
Closed -$247K – 345
2025
Q1 		$247K Buy
+9,473
New +$275K 0.34% 139

Other funds holding HP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's HP Position: Q1 2026 in Review

PharVision Advisers sold out of Helmerich & Payne (HP) in Q1 2026, closing a stake of 9,886 shares — an estimated $284K sold.

PharVision Advisers first reported a position in HP in Q1 2025 and held it in 2 quarters. The position peaked at $284K in Q4 2025. 375 funds tracked by Wall St. Rank hold HP as of Q1 2026.

  • PharVision Advisers reported no remaining Helmerich & Payne position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 9,886 Helmerich & Payne shares in Q1 2026, an estimated $284K.
  • PharVision Advisers first reported a position in Helmerich & Payne in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Helmerich & Payne position peaked at $284K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Helmerich & Payne as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.